Apoptotic mechanisms in the control of erythropoiesis

Erythropoiesis is a complex multistep process encompassing the differentiation of hemopoietic stem cells to mature erythrocytes. The steps involved in this complex differentiation process are numerous and involve first the differentiation to early erythoid progenitors (burst-forming units-erythroid, BFU-E), then to late erythroid progenitors (colony-forming units-erythroid) and finally to morphologically recognizable erythroid precursors. A key event of late stages of erythropoiesis is nuclear condensation, followed by extrusion of the nucleus to produce enucleated reticulocytes and finally mature erythrocytes. During the differentiation process, the cells became progressively sensitive to erythropoietin that controls both the survival and proliferation of erythroid cells.A normal homeostasis of the erythropoietic system requires an appropriate balance between the rate of erythroid cell production and red blood cell destruction. Growing evidences outlined in the present review indicate that apoptotic mechanism play a relevant role in the control of erythropoiesis under physiologic and pathologic conditions. Withdrawal of erythropoietin or stimulation of death receptors such as Fas or TRAIL-Rs leads to activation of a subset of caspase-3, -7 and -8, which then cleave the transcription factors GATA-1 and TAL-1 and trigger apoptosis. In addition, there is evidence that a number of caspases are physiologically activated during erythroid differentiation and are functionally required for erythroid maturation. Several caspase substrates are cleaved in differentiating cells, including the protein acinus whose activation by cleavage is required for chromatin condensation.The studies on normal erythropoiesis have clearly indicated that immature erythroid precursors are sensitive to apoptotic triggering mediated by activation of the intrinsic and extrinsic apoptotic pathways. These apoptotic mechanisms are frequently exacerbated in some pathologic conditions, associated with the development of anemia (ie, thalassemias, multiple myeloma, myelodysplasia, aplastic anemia).The considerable progress in our understanding of the apoptotic mechanisms underlying normal and pathologic erythropoiesis may offer the way to improve the treatment of several pathologic conditions associated with the development of anemia.

[1]  J. Eriksson,et al.  Erythroid Differentiation Sensitizes K562 Leukemia Cells to TRAIL-Induced Apoptosis by Downregulation of c-FLIP , 2003, Molecular and Cellular Biology.

[2]  E. Cundari,et al.  Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. , 1997, Cancer research.

[3]  R. Gregory,et al.  Signal transduction in the erythropoietin receptor system. , 1999, Experimental cell research.

[4]  G. Blobel,et al.  An abundant erythroid protein that stabilizes free alpha-haemoglobin. , 2002, Nature.

[5]  M. O'Dwyer,et al.  Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members. , 2000, Blood.

[6]  H. Perry,et al.  Renin and erythropoietin in normotensive and in hypertensive patients. , 1968, The Journal of laboratory and clinical medicine.

[7]  S. Schrier,et al.  Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe beta-thalassemia (Cooley's anemia) [see comments] , 1993 .

[8]  E. Kosmas,et al.  Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis. , 2001, Annals of internal medicine.

[9]  P. Hudgson,et al.  Renal artery stenosis with hypertension and high haematocrit. , 1967, British medical journal.

[10]  P. Kiener,et al.  A role for tumour necrosis factor‐α, Fas and Fas‐Ligand in marrow failure associated with myelodysplastic syndrome , 1998, British journal of haematology.

[11]  J. Myklebust,et al.  Differential Expression of Bcl‐2 Homologs in Human CD34+ Hematopoietic Progenitor Cells Induced to Differentiate into Erythroid or Granulocytic Cells , 2000, Stem cells.

[12]  Olivier Hermine,et al.  Platelet formation is the consequence of caspase activation within megakaryocytes. , 2002, Blood.

[13]  S H Kaufmann,et al.  Programmed cell death: alive and well in the new millennium. , 2001, Trends in cell biology.

[14]  S. Krantz,et al.  Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. , 1993, The Journal of clinical investigation.

[15]  C. Peschle,et al.  Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. , 2000, Blood.

[16]  B. Burgering,et al.  Cell cycle and death control: long live Forkheads. , 2002, Trends in biochemical sciences.

[17]  Peter Gustavsson,et al.  The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia , 1999, Nature Genetics.

[18]  Matthew G. Vander Heiden,et al.  Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? , 1999, Nature Cell Biology.

[19]  I. Bernstein,et al.  Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. , 1995, Blood.

[20]  S. B. Mckenzie.  Textbook of Hematology , 1988 .

[21]  P. Dent,et al.  Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia. , 2003, Blood.

[22]  J. Beckmann,et al.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.

[23]  S. Schrier,et al.  Enhanced macrophagic attack on beta-thalassemia major erythroid precursors. , 2002, Haematologica.

[24]  H. Deeg,et al.  Fas (CD95) receptor and Fas-ligand expression in bone marrow cells from patients with myelodysplastic syndrome. , 1996, Blood.

[25]  Shin-Chen Hou,et al.  Erythroid Gene Suppression by NF-κB* , 2003, Journal of Biological Chemistry.

[26]  S. Orkin,et al.  Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. , 1998, Genes & development.

[27]  C. Peschle,et al.  Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins. , 2003, Blood.

[28]  C. Kellendonk,et al.  The glucocorticoid receptor is required for stress erythropoiesis. , 1999, Genes & development.

[29]  S. Nagata,et al.  Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. , 1998, Blood.

[30]  F. Dammacco,et al.  Anemia in Multiple Myeloma: Role of Deregulated Plasma Cell Apoptosis , 2002, Leukemia & lymphoma.

[31]  E. Gordon-Smith,et al.  Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti‐thymocyte globulin: examination of the role of the Fas–Fas‐L interaction , 2000, British journal of haematology.

[32]  M. Birrer,et al.  Erythroid Cells Apoptosis in Erythropoietin-Dependent AP 1 Regulation of Proliferation and Initiation of , 1997 .

[33]  R. Schwartz.  Polycythemia vera--chance, death, and mutability. , 1998, The New England journal of medicine.

[34]  P. Vassilakos,et al.  Renin-angiotensin system stimulates erythropoietin secretion in chronic hemodialysis patients. , 1995, Clinical nephrology.

[35]  S. Schrier,et al.  The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with β-thalassemia major , 2000 .

[36]  N. Young,et al.  Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. , 1995, Blood.

[37]  G. Keller,et al.  Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. , 1994, Genes & development.

[38]  T. Koike,et al.  Tumor necrosis factor-α inhibits generation of glycophorin A+ cells by CD34+ cells , 2002 .

[39]  J. Dupont,et al.  In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes : evidence for Fas-dependent apoptosis , 2002 .

[40]  L. Zon,et al.  Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. , 1999, Development.

[41]  J. Wingard,et al.  Human CD34+ Hematopoietic Stem/Progenitor Cells Express High Levels of FLIP and Are Resistant to Fas‐Mediated Apoptosis , 2002, Stem cells.

[42]  C. Thompson,et al.  Pathways of Apoptosis in Lymphocyte Development, Homeostasis, and Disease , 2002, Cell.

[43]  B. Habermann,et al.  Apoptosis Protection by the Epo Target Bcl-XL Allows Factor-Independent Differentiation of Primary Erythroblasts , 2002, Current Biology.

[44]  G. Hicks,et al.  Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism. , 2000, Blood.

[45]  D. Sassoon,et al.  TNFα inhibits skeletal myogenesis through a PW1‐dependent pathway by recruitment of caspase pathways , 2002, The EMBO journal.

[46]  S. Fiering,et al.  Deoxyribonuclease IIα is required during the phagocytic phase of apoptosis and its loss causes perinatal lethality , 2002, Cell Death and Differentiation.

[47]  M. Raff,et al.  Caspase activation in the terminal differentiation of human epidermal keratinocytes , 1999, Current Biology.

[48]  J. Tschopp,et al.  The molecular architecture of the TNF superfamily. , 2002, Trends in biochemical sciences.

[49]  A. Miyajima,et al.  Role of cytokine signaling molecules in erythroid differentiation of mouse fetal liver hematopoietic cells: functional analysis of signaling molecules by retrovirus-mediated expression. , 1999, Blood.

[50]  A. Ashkenazi,et al.  Targeting death and decoy receptors of the tumour-necrosis factor superfamily , 2002, Nature Reviews Cancer.

[51]  B. Ames,et al.  Apoptosis of late-stage erythroblasts in megaloblastic anemia: association with DNA damage and macrocyte production. , 1997, Blood.

[52]  H. Beug,et al.  Raf-1 Antagonizes Erythroid Differentiation by Restraining Caspase Activation , 2002, The Journal of experimental medicine.

[53]  A. Green,et al.  Antisense SCL suppresses self‐renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. , 1991, The EMBO journal.

[54]  P. Driscoll,et al.  Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases. , 2002, Trends in biochemical sciences.

[55]  M. Capecchi,et al.  Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. , 2000, The Journal of clinical investigation.

[56]  F. Jirik,et al.  Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. , 2003, Blood.

[57]  S. Orkin,et al.  Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[58]  西尾 充史.  Stem Cell Factor Prevents Fas-Mediated Apoptosis of Human Erythroid Precursor Cells with Src-Family Kinase Dependency , 2001 .

[59]  J. Myklebust,et al.  Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells. , 2002, Experimental hematology.

[60]  D. Goeddel,et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.

[61]  C. Slomianny,et al.  Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria , 2001, Cell Death and Differentiation.

[62]  M. Koury,et al.  Apoptosis mediates and thymidine prevents erythroblast destruction in folate deficiency anemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Raff,et al.  Constitutive expression of the machinery for programmed cell death , 1996, The Journal of cell biology.

[64]  J. Puck,et al.  Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency , 2002, Nature.

[65]  R. Greil,et al.  Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. , 1997, Blood.

[66]  Ellen M. Langer,et al.  Bcl-xL Deamidation Is a Critical Switch in the Regulation of the Response to DNA Damage , 2002, Cell.

[67]  Haigen Huang,et al.  Stimulation of erythropoiesis by inhibiting a new hematopoietic death receptor in transgenic zebrafish , 2000, Nature Cell Biology.

[68]  V. Barr,et al.  Cloning and Characterization of a Gene Expressed during Terminal Differentiation That Encodes a Novel Inhibitor of Growth* , 2004, Journal of Biological Chemistry.

[69]  J. Marine,et al.  Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. , 2000, Genes & development.

[70]  L. Hennighausen,et al.  Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. , 2000, Development.

[71]  S. Orkin,et al.  Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene , 2003, Nature.

[72]  F. Dammacco,et al.  Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma. , 2002, Blood.

[73]  T. Ulich,et al.  Tumor necrosis factor exerts dose-dependent effects on erythropoiesis and myelopoiesis in vivo. , 1990, Experimental hematology.

[74]  H. Deeg,et al.  Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. , 2001, Blood.

[75]  N. Young.  Acquired Aplastic Anemia , 2002, Annals of Internal Medicine.

[76]  J. Postlethwait,et al.  Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency , 2003, Nature Genetics.

[77]  S. Srinivasula,et al.  Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 , 1999, Nature.

[78]  N. Madias,et al.  Posttransplant erythrocytosis. , 2003, Kidney international.

[79]  K. Takatsuki,et al.  Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. , 1997, Blood.

[80]  V. Rotter,et al.  The onset of p53-dependent apoptosis plays a role in terminal differentiation of human normoblasts , 2003, Oncogene.

[81]  J. Price,et al.  Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis. , 1998, Blood.

[82]  C. Dai,et al.  Interferon γ Induces Upregulation and Activation of Caspases 1, 3, and 8 to Produce Apoptosis in Human Erythroid Progenitor Cells , 1999 .

[83]  H. Hydén,et al.  A receptor for phosphatidylserine-speci ® c clearance of apoptotic cells , 2000 .

[84]  M. Raff,et al.  Are caspases involved in the death of cells with a transcriptionally inactive nucleus? Sperm and chicken erythrocytes. , 1998, Journal of cell science.

[85]  N. Motoyama,et al.  bcl-x Prevents Apoptotic Cell Death of Both Primitive and Definitive Erythrocytes at the End of Maturation , 1999, The Journal of experimental medicine.

[86]  M. Grompe,et al.  Tumor necrosis factor‐α and CD95 ligation suppress erythropoiesis in fanconi anemia C gene knockout mice , 1999, Journal of cellular physiology.

[87]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[88]  M. Bondurant,et al.  Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors , 1999, Journal of cellular physiology.

[89]  B. Zhivotovsky,et al.  Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. , 2003, Blood.

[90]  K. M. Nicholson,et al.  The protein kinase B/Akt signalling pathway in human malignancy. , 2002, Cellular signalling.

[91]  F. Prósper,et al.  Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell Lines* , 1999, The Journal of Biological Chemistry.

[92]  S. Jacobsen,et al.  Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors. , 1995, Blood.

[93]  Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. , 1994 .

[94]  H. Papadaki,et al.  Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. , 2002, Blood.

[95]  F. Vasseur,et al.  Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice. , 1999, Blood.

[96]  Miyuki Kobayashi,et al.  Significance of electron‐dense deposits in the mitochondrial matrix of erythroid precursors in aplastic anaemia and myelodysplastic syndrome , 1999, British journal of haematology.

[97]  G. Condorelli,et al.  Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. , 1998, Cancer research.

[98]  I. Dybedal,et al.  Self-Renewal of Multipotent Long-Term Repopulating Hematopoietic Stem Cells Is Negatively Regulated by FAS and Tumor Necrosis Factor Receptor Activation , 2001, The Journal of experimental medicine.

[99]  R. Means,et al.  Inhibition of human erythroid colony formation by ceramide. , 1999, Experimental hematology.

[100]  A. Khaled,et al.  Lymphocide: cytokines and the control of lymphoid homeostasis , 2002, Nature Reviews Immunology.

[101]  al. et,et al.  Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice , 1995, Science.

[102]  G. Condorelli,et al.  Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis. , 1995, The Journal of clinical investigation.

[103]  Wenli Liu,et al.  Hydroxyurea exerts bi‐modal dose‐dependent effects on erythropoiesis in human cultured erythroid cells via distinct pathways , 2002, British journal of haematology.

[104]  J. Lammers,et al.  FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal , 2002, The Journal of cell biology.

[105]  S. Kajigaya,et al.  Mitochondrial DNA mutations in patients with myelodysplastic syndromes. , 2003, Blood.

[106]  S. Srinivasula,et al.  Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1 , 2003, Cell Death and Differentiation.

[107]  N. Young,et al.  Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. , 2002, Blood.

[108]  D. Morrison,et al.  BCL-2 and BCL-XL Restrict Lineage Choice during Hematopoietic Differentiation* , 2003, Journal of Biological Chemistry.

[109]  Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. , 1997, Blood.

[110]  Genhong Cheng,et al.  The signaling adaptors and pathways activated by TNF superfamily. , 2003, Cytokine & growth factor reviews.

[111]  C. Dai,et al.  Stem cell factor increases the expression of FLIP that inhibits IFNgamma -induced apoptosis in human erythroid progenitor cells. , 2003, Blood.

[112]  P. Moitra,et al.  Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes , 2002, FEBS letters.

[113]  Keisuke Kuida,et al.  Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome , 2002, Nature.

[114]  B. Joseph,et al.  Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts , 2001, Leukemia.

[115]  E. Alnemri,et al.  TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. , 2000, Blood.

[116]  S. Schrier,et al.  Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe beta-thalassemia (Cooley's anemia) , 1993, Blood.

[117]  F. Gouilleux,et al.  IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line , 1999, Oncogene.

[118]  F. Dammacco,et al.  Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression. , 2001, Blood.

[119]  M. Fujishima,et al.  Worsening of Anemia by Angiotensin Converting Enzyme Inhibitors and Its Prevention by Antiestrogenic Steroid in Chronic Hemodialysis Patients , 1989, Journal of cardiovascular pharmacology.

[120]  E. Dessypris,et al.  Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells. , 1990, The Journal of clinical investigation.

[121]  Olivier Hermine,et al.  Caspase Activation Is Required for Terminal Erythroid Differentiation , 2001, The Journal of experimental medicine.

[122]  H. Beug,et al.  Protein Kinase C α Controls Erythropoietin Receptor Signaling* , 2000, The Journal of Biological Chemistry.

[123]  Ming Xu,et al.  Apoptotic DNA fragmentation and tissue homeostasis. , 2002, Trends in cell biology.

[124]  M. Kawakami,et al.  Effects of recombinant human tumor necrosis factor (rhTNF) on normal human and mouse hemopoietic progenitor cells. , 1987, International journal of cell cloning.

[125]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[126]  G. Condorelli,et al.  Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. , 1994, The American journal of cardiology.

[127]  J. Pfeilschifter,et al.  New insights into the mechanism for clearance of apoptotic cells. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[128]  J. Puck,et al.  Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type II , 1999, Cell.

[129]  D. Altieri.  Validating survivin as a cancer therapeutic target , 2003, Nature Reviews Cancer.

[130]  J. D. Vos,et al.  Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes , 1997, Leukemia.

[131]  N. Madias,et al.  Posttransplant erythrocytosis. , 2003, Kidney international.

[132]  I. Dimopoulou,et al.  Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. , 1999, The American journal of medicine.

[133]  Z. Zhao,et al.  Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis , 1998 .

[134]  J. Yu,et al.  Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis. , 1998, Cancer research.

[135]  J. Adamson,et al.  FERROKINETICS IN MAN , 1970, Medicine.

[136]  S. Orkin,et al.  GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. , 1999, Blood.

[137]  Mason R. Mackey,et al.  Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane , 2002, Cell.

[138]  N. Young,et al.  Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia , 1995, British journal of haematology.

[139]  F. Ramos,et al.  What does apoptosis have to do with clinical features in myelodysplastic syndrome? , 2002, Haematologica.

[140]  M. Bondurant,et al.  The function of the bcl-x promoter in erythroid progenitor cells. , 2003, Blood.

[141]  A. Mui,et al.  STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells , 1999, The EMBO journal.

[142]  A. Khwaja,et al.  Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. , 2001, Blood.

[143]  M. Raff,et al.  A Role for Caspases in Lens Fiber Differentiation , 1998, The Journal of cell biology.

[144]  E. Estey,et al.  Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome. , 2003, Blood.

[145]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[146]  H. Pahl.  Towards a molecular understanding of polycythemia rubra vera. , 2000, European journal of biochemistry.

[147]  H. Preisler,et al.  Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. , 1995, Blood.

[148]  K. Ozawa,et al.  Activation of extracellular signal‐regulated kinases ERK1 and ERK2 induces Bcl‐xL up‐regulation via inhibition of caspase activities in erythropoietin signaling , 2003, Journal of cellular physiology.

[149]  P. Devarajan,et al.  Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis. , 2001, Journal of the American Society of Nephrology : JASN.

[150]  H. Beug,et al.  Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[151]  K. Takenaka,et al.  In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). , 1996, Blood.

[152]  N. Hanania,et al.  Bcl-XL is required for heme synthesis during the chemical induction of erythroid differentiation of murine erythroleukemia cells independently of its antiapoptotic function. , 2003, Blood.

[153]  S. Krantz,et al.  Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. , 1998, Blood.

[154]  H. Lodish,et al.  Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. , 2001, Blood.

[155]  M. Labeeuw,et al.  Renal venous erythropoietin concentrations in hypertensive patients with unilateral renal disease. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[156]  J. Blenis,et al.  Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8* , 2001, The Journal of Biological Chemistry.

[157]  L. Perey,et al.  Apoptotic regulation in primitive hematopoietic precursors. , 1998, Blood.

[158]  H. Papadaki,et al.  Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. , 2002, Blood.

[159]  美仁 長谷山.  Phosphatidylinositol 3-Kinase Is Involved in the Protection of Primary Cultured Human Erythroid Precursor Cells From Apoptosis , 2001 .

[160]  S. Nagata,et al.  Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. , 2001, Science.

[161]  S. Fukuda,et al.  The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. , 2002, Blood.

[162]  I. H. Engels,et al.  Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis , 2001, Cell Death and Differentiation.

[163]  G. Kroemer,et al.  Genetic analysis of the mammalian cell death machinery. , 2002, Trends in genetics : TIG.

[164]  Johan Richter,et al.  Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia. , 2002, Blood.

[165]  N. Kabra,et al.  Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.

[166]  B. Aggarwal,et al.  Receptor-Mediated Choreography of Life and Death , 2003, Journal of Clinical Immunology.

[167]  C. Ware.  The TNF superfamily. , 2003, Cytokine & growth factor reviews.

[168]  A. Wickrema,et al.  Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin. , 2000, Blood.

[169]  H. Deeg,et al.  HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand. , 1997, Journal of immunology.

[170]  D. Green,et al.  Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils , 2002, Nature Medicine.

[171]  L. Zon,et al.  Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[172]  S. Schrier.  Pathophysiology of thalassemia , 2002, Current opinion in hematology.

[173]  Shin-Chen Hou,et al.  Erythroid gene suppression by NF-kappa B. , 2003, The Journal of biological chemistry.

[174]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[175]  H. Meiselman,et al.  Ineffective erythropoiesis in beta-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage. , 2000, Experimental hematology.

[176]  C. Peschle,et al.  Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. , 1996, Blood.

[177]  E. Mechetner,et al.  Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. , 1996, Blood.

[178]  J. Spivak,et al.  Polycythemia vera: myths, mechanisms, and management. , 2002, Blood.

[179]  C. Nissen,et al.  Intracellular Fas ligand is elevated in T lymphocytes in severe aplastic anaemia , 2001, British journal of haematology.

[180]  C. Richard,et al.  Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. , 1998, The New England journal of medicine.

[181]  A. Miyajima,et al.  Constitutive Activation of STAT5 by a Point Mutation in the SH2 Domain* , 2000, The Journal of Biological Chemistry.

[182]  S. Schrier,et al.  A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia. , 2000, Blood.

[183]  G. Stassi,et al.  Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. , 1999, Blood.

[184]  S. Orkin,et al.  Transcriptional regulation of erythropoiesis: an affair involving multiple partners , 2002, Oncogene.

[185]  B. Hemmings,et al.  PKB Binding Proteins Getting in on the Akt , 2002, Cell.

[186]  B. Julian,et al.  Angiotensin II stimulates proliferation of normal early erythroid progenitors. , 1997, The Journal of clinical investigation.

[187]  J. Goldman,et al.  A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics. , 2002, Experimental hematology.

[188]  M. Birrer,et al.  AP1 Regulation of Proliferation and Initiation of Apoptosis in Erythropoietin-Dependent Erythroid Cells , 1998, Molecular and Cellular Biology.

[189]  C. Lacombe,et al.  Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. , 2003, Blood.

[190]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[191]  M. Seldin,et al.  Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. , 1997, Journal of immunology.

[192]  Y. Fujio,et al.  Glycoprotein 130 Regulates Cardiac Myocyte Survival in Doxorubicin-Induced Apoptosis Through Phosphatidylinositol 3-Kinase/Akt Phosphorylation and Bcl-xL/Caspase-3 Interaction , 2001, Circulation.

[193]  P. Toselli,et al.  BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation. , 2002, Blood.

[194]  G. Narla,et al.  Ribosomal protein S19 expression during erythroid differentiation. , 2003, Blood.

[195]  S. Kajigaya,et al.  Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers. , 2004, Blood.

[196]  Masayuki Yamamoto,et al.  Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels. , 2003, Blood.

[197]  K. Ozawa,et al.  A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. , 2000, Blood.

[198]  M. Bondurant,et al.  The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. , 1997, Blood.

[199]  E. Solary,et al.  Specific involvement of caspases in the differentiation of monocytes into macrophages. , 2002, Blood.

[200]  F. Hanaoka,et al.  Molecular biology of Fanconi anaemia—an old problem, a new insight , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[201]  Scott W. Lowe,et al.  Apoptosis A Link between Cancer Genetics and Chemotherapy , 2002, Cell.

[202]  H. Lodish,et al.  The Cytokine-inducible Scr Homology Domain-containing Protein Negatively Regulates Signaling by Promoting Apoptosis in Erythroid Progenitor Cells* , 2003, The Journal of Biological Chemistry.

[203]  Joyoti Basu,et al.  Caspase 3-mediated Proteolysis of the N-terminal Cytoplasmic Domain of the Human Erythroid Anion Exchanger 1 (Band 3)* , 2003, Journal of Biological Chemistry.

[204]  L. Moldawer,et al.  Cachectin/tumor necrosis factor‐α alters red blood cell kinetics and induces anemia in vivo , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[205]  R. Invernizzi.  The role of apoptosis in myelodysplastic syndrome. , 2002, Haematologica.

[206]  P. Secchiero,et al.  TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. , 2004, Blood.

[207]  H. Lodish,et al.  Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.

[208]  P. Devarajan,et al.  Angiotensin-Converting Enzyme Inhibition Induces Death Receptor Apoptotic Pathways in Erythroid Precursors following Renal Transplantation , 2003, American Journal of Nephrology.

[209]  M. Grompe,et al.  Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. , 1997, Blood.

[210]  C. Mathew,et al.  Interaction of FANCD2 and NBS1 in the DNA damage response , 2002, Nature Cell Biology.